McCarthy Asset Management’s AbbVie ABBV Stock Holding History

McCarthy Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-643	Closed	-$104K	–	34
2022 Q1	$104K	Buy	643 +1	+0.2%	+$145	0.07%	55
2021 Q4	$87K	Hold	642	–	–	0.06%	62
2021 Q3	$69K	Buy	642 +1	+0.2%	+$114	0.05%	70
2021 Q2	$72K	Sell	641 -1,860	-74%	-$209K	0.05%	72
2021 Q1	$271K	Sell	2,501 -205	-8%	-$21.9K	0.21%	29
2020 Q4	$290K	Buy	+2,706	New	+$260K	0.24%	28

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McCarthy Asset Management's ABBV Position: Q2 2022 in Review

McCarthy Asset Management sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 643 shares — an estimated $104K sold.

McCarthy Asset Management first reported a position in ABBV in Q4 2020 and held it in 6 quarters. The position peaked at $290K in Q4 2020. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

McCarthy Asset Management reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 643 AbbVie shares in Q2 2022, an estimated $104K.
McCarthy Asset Management first reported a position in AbbVie in Q4 2020 and held it in 6 quarters.
McCarthy Asset Management's AbbVie position peaked at $290K in Q4 2020.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.